Stockreport

Prenetics Reinforces Strategic Focus on IM8, Divests Europa Business For Up to $13 Million

Prenetics Global Limited - Class A Ordinary Share  (PRE) 
PDF Company Continues Portfolio Optimization on the Heels of Successful $72 million ACT Genomics sale Company Maintains Strong Balance Sheet with over $70 million in Cash a [Read more]